Regulation of cardiac miR-208a, an inducer of obesity, by Rapamycin and Nebivolol

OBJECTIVE: Resistance to obesity is observed in rodents and humans treated with Rapamycin (Rap) or Nebivolol (Neb). Since cardiac miR-208a promotes obesity, we tested whether the modes of actions of Rap and Neb involve inhibition of miR-208a. METHODS: Mouse cardiomyocyte HL-1 cells and Zucker obese...

Descripción completa

Detalles Bibliográficos
Autores principales: Gul, Rukhsana, Mahmood, Abuzar, Luck, Christian, Lum-Naihe, Kelly, Alfadda, Assim A, Speth, Robert C., Pulakat, Lakshmi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4633375/
https://www.ncbi.nlm.nih.gov/pubmed/26381051
http://dx.doi.org/10.1002/oby.21227

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4633375/
https://www.ncbi.nlm.nih.gov/pubmed/26381051
http://dx.doi.org/10.1002/oby.21227

Ejemplares similares